
Privilège Ventures
Europe, Ticino, Switzerland, Lugano
Description
Swiss-based Venture Capital firm authorised by FINMA investing in seed stage companies
Investor Profile
Privilège Ventures has made 18 investments, with 1 in the past 12 months and 44% as lead.
Stage Focus
- Seed (67%)
- Series A (11%)
- Series Unknown (11%)
- Pre Seed (11%)
Country Focus
- Switzerland (83%)
- Italy (6%)
- France (6%)
Industry Focus
- Health Care
- Software
- Wearables
- Biotechnology
- Hardware
- Robotics
- Health Diagnostics
- Medical Device
- Renewable Energy
- Artificial Intelligence (Ai)
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.